Establish TIIC signature score based the machine learning fusion in bladder cancer
This study successfully constructed and validated an RNA signature scoring system based on tumor-infiltrating immune cell (TIIC) features, which can effectively predict OS and the effectiveness of immunotherapy in bladder cancer patients.
Authors
- Hao Su (ORCID: https://orcid.org/0000-0002-7621-8730)
- Zhijie Lu (ORCID: https://orcid.org/0000-0002-0561-0591)
- Caixia Dai
- Shunhua Cheng (ORCID: https://orcid.org/0009-0002-0474-9505)
- Xiangju Zeng
- Ziqi Liu (ORCID: https://orcid.org/0000-0002-4112-3504)
Institutions
- Central South University (CN)
- Hunan University (CN)
- Second Xiangya Hospital of Central South University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1007/s12672-024-01187-7
- Citations
- 2
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.15